Y03021H Recombinant Human LIF Product Brochure

≤10 EU/mg by the LAL method.

Measured by its ability to inhibit the proliferation of M1 mouse myeloid leukemia cells. The ED₅₀ for this effect is typically ＜0.5 ng/mL.

Leukemia Inhibitory Factor; LIF; Differentiation-Stimulating Factor; D Factor; Melanoma-Derived LPL Inhibitor; MLPLI; Emfilermin; LIF; HILDA

Ser23-F202

Tag free

Lyophilized

Lyophilized from a 0.22 μm-filtered solution containing 10 mM PB, 5% Trehalose and 0.01% Tween 80, pH7.4.

10μg/50μg/1mg

Products are in stock, but custom products may require further consultation.

It is recommended to redissolve in sterile deionized water.

The product is shipped with blue ice.

36 months at -20°C to -80°C in lyophilized state;

6 months at -20°C to -80°C under sterile conditions after reconstitution;

7-10 days at 2°C to 8°C under sterile conditions after reconstitution;

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.